(Q51365311)

4 April 2018

title

Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis. (English)

1 reference

4 April 2018

1 reference

7

1 reference

4 April 2018

author name string

Yao-Chung Chuang

1

1 reference

4 April 2018

Hung-Yi Chuang

2

1 reference

4 April 2018

Tsu-Kung Lin

3

1 reference

4 April 2018

Chiung-Chih Chang

4

1 reference

4 April 2018

Cheng-Hsien Lu

5

1 reference

4 April 2018

Wen-Neng Chang

6

1 reference

4 April 2018

Teng-Yeow Tan

8

1 reference

4 April 2018

Chi-Ren Huang

9

1 reference

4 April 2018

Samuel H H Chan

10

1 reference

4 April 2018

publication date

15 November 2011

1 reference

4 April 2018

published in

Epilepsia

1 reference

4 April 2018

volume

53

1 reference

4 April 2018

issue

1

1 reference

4 April 2018

page(s)

120-128

1 reference

4 April 2018

Behaviour, cognition and epilepsy

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Serum total homocysteine concentrations and risk of mortality from stroke and coronary heart disease in Japanese: The JACC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Blood homocysteine, folate and vitamin B-12 concentrations in patients with epilepsy receiving lamotrigine or sodium valproate for initial monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Adverse effects of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Mortality in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Conditional risk factors for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Early identification of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Antiepileptic drugs and markers of vascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Metabolic consequences of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Should enzyme-inducing antiepileptic drugs be considered first-line agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Effects of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Role of oxidative modifications in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Long-term antiepileptic drug therapy contributes to the acceleration of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Factors associated with gender difference in the intima-media thickness of the common carotid artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Homocysteine as a risk factor for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Effects of AEDs on biomarkers in people with epilepsy: CRP, HbA1c and eGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Mortality from epilepsy: results from a prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

Mortality in epilepsy in the first 11 to 14 years after diagnosis: Multivariate analysis of a long-term, prospective, population-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03316.X

10.1111/J.1528-1167.2011.03316.X

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018